Company / Gross Profit
TELA Bio, Inc. Gross Profit History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit
$40.1M
FY2025
5-year range
$9.3M / $40.1M
FY2021-FY2025
Trend
+48.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit has increased for 6 consecutive years, from $3M in FY2019 to $40M in FY2025.
Based on SEC 10-K filings.
$40M in FY2025 with a 5-year CAGR of +68.6%.
Improved from $19M to $40M over the past 2 years.
Gross Profit over time
Growth rates
- 3-Year CAGR
- +52.8%
- 5-Year CAGR
- +68.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- TELA Bio, Inc.'s gross profit has grown for 6 consecutive years.
- 5-year CAGR of +68.6%, indicating consistent growth.
- In FY2025, gross profit increased 48.3% year-over-year.
- Lowest gross profit in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross ProfitValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $40.1M | +48.3% |
| FY2024 | $27.0M | +43.8% |
| FY2023 | $18.8M | +67.5% |
| FY2022 | $11.2M | +21.2% |
| FY2021 | $9.3M | +215.2% |
| FY2020 | $2.9M | +16.2% |
| FY2019 | $2.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026